The goal of the Protocol Review and Monitoring System (PRMS) at the Wake Forest Baptist Comprehensive Cancer Center (WFBCCC) is to provide systematic internal review and oversight of all cancer-related studies without duplicating traditional peer review.
The Specific Aims of the PRMS are to 1) prioritizing all cancer clinical trials, regardless of source, proposed to be conducted at Wake Forest Baptist Medical Center; 2) reviewing the scientific merit of all investigator-initiated cancer clinical trials proposed to be conducted at Wake Forest Baptist Medical Center; and 3) conducting ongoing review of study accrual and scientific progress of WFBCCC clinical trials. The PRMS process is supported by Disease-Oriented Teams, the Operations Protocol Service, the Protocol Review Committee, and the Clinical Research Oversight Committee. Cancer-related protocols thus are initially developed by Disease-Oriented Team concept review, prioritized within the Disease- Oriented Team portfolio, and then reviewed by the Operations Protocol Service for logistical considerations and the Protocol Review Committee for scientific merit and final prioritization. Monitoring of accrual and scientific progress, including biostatistical reports and interim endpoint analyses, are carried out by the Clinical Research Oversight Committee, with Disease-Oriented Team support. In the most recent grant year, 111 trials were reviewed by the Protocol Review Committee and 280 trials were monitored by the Clinical Research Oversight Committee.
|Chouliaras, Konstantinos; Levine, Edward A; Fino, Nora et al. (2017) Prognostic Factors and Significance of Gastrointestinal Leak After Cytoreductive Surgery (CRS) with Heated Intraperitoneal Chemotherapy (HIPEC). Ann Surg Oncol 24:890-897|
|Wang, Lulu; Habib, Amyn A; Mintz, Akiva et al. (2017) Phosphatidylserine-Targeted Nanotheranostics for Brain Tumor Imaging and Therapeutic Potential. Mol Imaging 16:1536012117708722|
|Keim-Malpass, Jessica; Mihalko, Shannon L; Russell, Greg et al. (2017) Problems Experienced by Ovarian Cancer Survivors During Treatment. J Obstet Gynecol Neonatal Nurs 46:544-554|
|Ivey, Jill W; Latouche, Eduardo L; Richards, Megan L et al. (2017) Enhancing Irreversible Electroporation by Manipulating Cellular Biophysics with a Molecular Adjuvant. Biophys J 113:472-480|
|Rohlfing, Matthew L; Mays, Ashley C; Isom, Scott et al. (2017) Insurance status as a predictor of mortality in patients undergoing head and neck cancer surgery. Laryngoscope 127:2784-2789|
|Soto-Pantoja, David R; Wilson, Adam S; Clear, Kenysha Yj et al. (2017) Unfolded protein response signaling impacts macrophage polarity to modulate breast cancer cell clearance and melanoma immune checkpoint therapy responsiveness. Oncotarget 8:80545-80559|
|Park, Sun H; Eber, Matthew R; Tsuzuki, Shunsuke et al. (2017) Adeno-associated virus serotype rh10 is a useful gene transfer vector for sensory nerves that innervate bone in immunodeficient mice. Sci Rep 7:17428|
|Andrews, Rachel N; Metheny-Barlow, Linda J; Peiffer, Ann M et al. (2017) Cerebrovascular Remodeling and Neuroinflammation is a Late Effect of Radiation-Induced Brain Injury in Non-Human Primates. Radiat Res 187:599-611|
|Carpenter, Richard L; Sirkisoon, Sherona; Zhu, Dongqin et al. (2017) Combined inhibition of AKT and HSF1 suppresses breast cancer stem cells and tumor growth. Oncotarget 8:73947-73963|
|Wajih, Nadeem; Basu, Swati; Jailwala, Anuj et al. (2017) Potential therapeutic action of nitrite in sickle cell disease. Redox Biol 12:1026-1039|
Showing the most recent 10 out of 481 publications